At Ancora.ai , we recognize the need for an easier way to find clinical trials. Currently, only 3–5% of cancer patients participate in clinical trials. Additionally, there is lack of diversity in the patients that participate in trials. We want to change that. We have experienced firsthand the challenges many patients face including the lack of awareness of trials and the difficulty of finding relevant trials. We believe that everyone should be able to access clinical research, and that technology can help unlock trial information and trial access for the broader population.
To evaluate our progress on our mission, we analyzed one year of data to understand who we were able to reach with our digital tool and how we were able to support them in accessing trials as part of our first impact report.
We would like to thank all the patients, families and healthcare practitioners who have used Ancora.ai and supported our mission. We’d also like to thank our partners who have been instrumental in expanding our reach and impact.
To our readers, we hope you enjoy our first impact report and we strongly encourage anyone to reach out who is interested to join us on the journey to make clinical trials more accessible to all.
For a deeper look into the survey’s findings, read the full report.
Thank you to our partners for helping amplify our work: